The identification of the enzyme plasmin as a defence against cancer cells that have spread to the brain, and of tumour-cell serpin proteins that inhibit plasmin production, outlines a mechanism for the formation of brain metastases.
This is a preview of subscription content, log in via an institution to check access.
References
Sporn, M. B. Lancet 347, 1377–1381 (1996).
Maher, E. A., Mietz, J., Arteaga, C. L., DePinho, R. A. & Mohla, S. Cancer Res. 69, 6015–6020 (2009).
Mehlen, P. & Puisieux, A. Nature Rev. Cancer 6, 449–458 (2006).
Valiente, M. et al. Cell 156, 1002–1016 (2014).
Heyn, C. et al. Magn. Reson. Med. 56, 1001–1010 (2006).
Kienast, Y. et al. Nature Med. 16, 116–122 (2010).
Croucher, D. R., Saunders, D. N., Lobov, S. & Ranson, M. Nature Rev. Cancer 8, 535–545 (2008).
Bao, S. et al. Cancer Res. 68, 6043–6048 (2008).
Felding-Habermann, B. et al. J. Cell Biol. 139, 1567–1581 (1997).
Erler, J. T. & Linding, R. J. Pathol. 220, 290–296 (2010).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Erler, J. Disabling defences in the brain. Nature 508, 46–47 (2014). https://doi.org/10.1038/508046a
Published:
Issue Date:
DOI: https://doi.org/10.1038/508046a
- Springer Nature Limited